Efinopegdutide
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for Efinopegdutide, covering 2023-11-15 to 2026-03-02. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Study of Efinopegdutide in People With Compensated Cirrhosis Due to Steatohepatitis (MK-6024-017) [Phase 2]